Windtree Therapeutics (WINT) Competitors $0.50 -0.01 (-1.95%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends WINT vs. SQZ, PKBO, TCBP, TCON, GNCAQ, GNCA, ALVO, ELOX, VECT, and GRTSShould you be buying Windtree Therapeutics stock or one of its competitors? The main competitors of Windtree Therapeutics include SQZ Biotechnologies (SQZ), Peak Bio (PKBO), TC Biopharm (TCBP), TRACON Pharmaceuticals (TCON), Genocea Biosciences (GNCAQ), Genocea Biosciences (GNCA), Alvotech (ALVO), Eloxx Pharmaceuticals (ELOX), VectivBio (VECT), and Gritstone bio (GRTS). These companies are all part of the "biological products, except diagnostic" industry. Windtree Therapeutics vs. SQZ Biotechnologies Peak Bio TC Biopharm TRACON Pharmaceuticals Genocea Biosciences Genocea Biosciences Alvotech Eloxx Pharmaceuticals VectivBio Gritstone bio SQZ Biotechnologies (NYSE:SQZ) and Windtree Therapeutics (NASDAQ:WINT) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, profitability, earnings, community ranking, valuation, institutional ownership, analyst recommendations and media sentiment. Do institutionals and insiders hold more shares of SQZ or WINT? 38.5% of SQZ Biotechnologies shares are held by institutional investors. Comparatively, 29.3% of Windtree Therapeutics shares are held by institutional investors. 16.0% of SQZ Biotechnologies shares are held by insiders. Comparatively, 0.9% of Windtree Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the media prefer SQZ or WINT? In the previous week, SQZ Biotechnologies' average media sentiment score of 0.00 equaled Windtree Therapeutics'average media sentiment score. Company Overall Sentiment SQZ Biotechnologies Neutral Windtree Therapeutics Neutral Which has higher valuation & earnings, SQZ or WINT? Windtree Therapeutics has lower revenue, but higher earnings than SQZ Biotechnologies. Windtree Therapeutics is trading at a lower price-to-earnings ratio than SQZ Biotechnologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSQZ Biotechnologies$18.16M0.05-$79.46M-$2.61-0.01Windtree TherapeuticsN/AN/A-$20.29M-$27.71-0.02 Does the MarketBeat Community prefer SQZ or WINT? SQZ Biotechnologies received 7 more outperform votes than Windtree Therapeutics when rated by MarketBeat users. Likewise, 66.67% of users gave SQZ Biotechnologies an outperform vote while only 50.00% of users gave Windtree Therapeutics an outperform vote. CompanyUnderperformOutperformSQZ BiotechnologiesOutperform Votes1066.67% Underperform Votes533.33% Windtree TherapeuticsOutperform Votes350.00% Underperform Votes350.00% Is SQZ or WINT more profitable? Windtree Therapeutics has a net margin of 0.00% compared to SQZ Biotechnologies' net margin of -369.96%. SQZ Biotechnologies' return on equity of -119.83% beat Windtree Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets SQZ Biotechnologies-369.96% -119.83% -59.90% Windtree Therapeutics N/A -347.82%-81.41% Which has more risk & volatility, SQZ or WINT? SQZ Biotechnologies has a beta of 2.34, meaning that its share price is 134% more volatile than the S&P 500. Comparatively, Windtree Therapeutics has a beta of 0.64, meaning that its share price is 36% less volatile than the S&P 500. Do analysts prefer SQZ or WINT? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SQZ Biotechnologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Windtree Therapeutics 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummarySQZ Biotechnologies beats Windtree Therapeutics on 10 of the 13 factors compared between the two stocks. Ad Colonial Metals“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide! Get Windtree Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for WINT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WINT vs. The Competition Export to ExcelMetricWindtree TherapeuticsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$297,000.00$3.03B$5.21B$8.85BDividend YieldN/A1.86%5.53%4.08%P/E Ratio-0.0225.7783.3415.60Price / SalesN/A312.191,247.8087.92Price / CashN/A172.5640.9736.92Price / Book0.054.607.206.55Net Income-$20.29M-$41.63M$119.63M$226.22M7 Day Performance5.87%2.57%2.12%3.77%1 Month Performance-43.67%-2.51%-2.43%4.64%1 Year Performance-97.06%28.21%34.55%29.21% Windtree Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WINTWindtree Therapeutics0.7469 of 5 stars$0.50-1.9%N/A-97.1%$297,000.00N/A-0.0220SQZSQZ BiotechnologiesN/A$0.03flatN/A+80.4%$826,000.00$18.16M-0.011,620Gap UpPKBOPeak BioN/A$0.02-67.9%N/A-61.2%$520,000.00$370,000.00-0.143Gap DownHigh Trading VolumeTCBPTC Biopharm0.1624 of 5 stars$0.62-1.6%N/A-99.4%$330,000.00$4.76M0.0041TCONTRACON Pharmaceuticals1.1807 of 5 stars$0.03flat$60.00+190,074.3%-99.2%$100,000.00$12.05M0.0120Analyst ForecastGNCAQGenocea BiosciencesN/AN/AN/AN/A$6,000.00$1.64M0.0070GNCAGenocea BiosciencesN/AN/AN/AN/A$6,000.00$1.91M0.0070ALVOAlvotech2.1142 of 5 stars$11.99-3.6%$18.00+50.1%+29.6%$0.00$93.38M0.001,026ELOXEloxx PharmaceuticalsN/AN/AN/AN/A$0.00N/A0.0018Gap UpVECTVectivBioN/A$16.85flatN/AN/A$0.00$27.34M0.0030High Trading VolumeGRTSGritstone bio1.1388 of 5 starsN/A$2.17+∞N/A$3.50M$496,000.00-0.03190News CoverageGap DownHigh Trading Volume Related Companies and Tools Related Companies SQZ Competitors PKBO Competitors TCBP Competitors TCON Competitors GNCAQ Competitors GNCA Competitors ALVO Competitors ELOX Competitors VECT Competitors GRTS Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:WINT) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Windtree Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Windtree Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
